Intuitive Surgical (NASDAQ:ISRG) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Intuitive Surgical (NASDAQ:ISRG) announced its quarterly earnings data on Thursday. The medical equipment provider reported $2.37 earnings per share for the quarter, missing the consensus estimate of $2.48 by ($0.11), Zacks reports. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $13.36 during trading hours on Thursday, hitting $402.33. The stock had a trading volume of 5,129,080 shares, compared to its average volume of 2,222,005. The company has a 50 day simple moving average of $418.39 and a two-hundred day simple moving average of $469.98. The firm has a market capitalization of $142.49 billion, a price-to-earnings ratio of 48.77, a P/E/G ratio of 3.09 and a beta of 1.46. Intuitive Surgical has a one year low of $378.50 and a one year high of $603.88.

Insider Transactions at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently bought and sold shares of ISRG. Amundi lifted its position in Intuitive Surgical by 29.7% in the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Intuitive Surgical by 9.4% during the fourth quarter. Wellington Management Group LLP now owns 3,445,880 shares of the medical equipment provider’s stock worth $1,951,609,000 after acquiring an additional 294,651 shares in the last quarter. California Public Employees Retirement System raised its stake in shares of Intuitive Surgical by 42.7% during the fourth quarter. California Public Employees Retirement System now owns 889,727 shares of the medical equipment provider’s stock worth $503,906,000 after acquiring an additional 266,380 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $110,557,000. Finally, Two Sigma Investments LP lifted its holdings in shares of Intuitive Surgical by 37.5% in the 3rd quarter. Two Sigma Investments LP now owns 551,017 shares of the medical equipment provider’s stock worth $246,431,000 after acquiring an additional 150,146 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Royal Bank Of Canada cut their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a research report on Monday. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a research note on Monday, July 6th. BMO Capital Markets assumed coverage on Intuitive Surgical in a research report on Wednesday, July 8th. They set an “outperform” rating and a $518.00 target price on the stock. TD Cowen reduced their price target on Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating for the company in a research report on Monday. Finally, Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $562.62.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical announced second-quarter earnings, which could provide a catalyst if results show continued demand for da Vinci systems and strong procedure growth. Intuitive Announces Second Quarter Earnings
• Positive Sentiment: Truist Financial kept a buy rating on ISRG, even after lowering its price target to $510 from $580, signaling analysts still see upside from current levels.
• Positive Sentiment: BMO Capital initiated coverage on Intuitive Surgical with an Outperform rating, adding to bullish sentiment around the stock.
• Positive Sentiment: Several reports highlighted ongoing growth opportunities from Intuitive’s AI-enabled da Vinci 5 rollout and its Ion lung biopsy platform, suggesting additional long-term revenue drivers beyond core surgery systems.
• Neutral Sentiment: Options traders are pricing in a large post-earnings move, reflecting elevated uncertainty rather than a clear directional bet. Options Traders Brace for ISRG Earnings – Here’s the Expected Stock Range
• Neutral Sentiment: Market commentary ahead of earnings focused on whether ISRG can defend leadership as global robotic-surgery competition intensifies, a longer-term competitive issue that is not necessarily an immediate earnings hit. Can ISRG Defend Its Leadership as Global Competition Intensifies?
• Negative Sentiment: Investor concern persists over the April 2026 Class II worldwide recall of certain da Vinci components, which has raised questions about product reliability and near-term sentiment. Intuitive Surgical (ISRG) Is Down 6.3% After Class II Recall of da Vinci Components Has The Bull Case Changed?

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.